WebSep 19, 2024 · Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in primary and revision hip arthroplasty in Japan. WebEnrolment options. This module will provide learners with the history, the concept and the philosophy of the OR3O Dual Mobility system, a modular design offering the benefits of the clinically-proven OXINIUM and highly cross linked polyethylene bearing along with a new proprietary bearing material, OXINIUM DH 1,2. Experts will drive us through ...
New data underscores material benefits of Smith+Nephew
WebMay 14, 2024 · Smith+Nephew's OR3O Dual Mobility System is available in the United States for both primary and revision applications and offers cross-compatibility with the R3(TM) and REDAPT(TM) acetabular systems. Invitation to Smith+Nephew Virtual Experience OR3O will be showcased at Smith+Nephew's virtual experience. Replacing cancelled in-person … WebMay 14, 2024 · Smith+Nephew's OR3O Dual Mobility System is available in the United States for both primary and revision applications and offers cross-compatibility with the R3 ™ … greens candidate for north sydney
New data underscores material benefits of Smith+Nephew
WebAug 31, 2024 · The Company's extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative... WebNov 8, 2024 · Smith+Nephew's OR3O Dual Mobility System is available in the United States for both primary and revision applications and offers cross-compatibility with the R3 and … WebSep 22, 2024 · On September 20, 2024, Smith+Nephew, a leading global portfolio medical technology business, announced the launch of OR3O Dual Mobility System for use in primary and revision hip arthroplasty in Japan. For its liner and femoral head, OR3O uses Smith+Nephew’s most recent advanced bearing surface, OXINIUM DH, as well as its own … greens candidate hornsby